Mesothelioma Cancer Centers
The Cleveland Clinic
Doctors Affiliated with this Treatment Facility
The Cleveland Clinic is a nonprofit medical center integrating clinical and hospital care with research and education. Founded in 1921, the Cleveland Clinic has grown to become one of the largest facilities in the United States.
Cancer care at the Cleveland Clinic is offered at the Taussig Cancer Center. Mesothelioma patients receive care within the Lung Cancer Program. The program treats patients with a multidisciplinary approach using the expertise of medical oncologists, pulmonologists, radiation oncologists, pathologists, thoracic surgeons and thoracic radiologists to provide the most favorable treatment options.
The new facility within the Taussig Cancer Center enables physicians to work in specialized teams according to cancer type. The physicians are supported by equally specialized nurses, social workers and other support staff in order to provide well-rounded care for the patient. The center offers a variety of personalized treatment options including chemotherapy, video-assisted thoracic surgery (VATS), extrapleural pneumonectomy, radiation oncology and immunotherapy.
Mesothelioma patients treated at the Cleveland Clinic benefit from their wide network of doctors. The Cleveland Clinic Cancer Center employs more than 400 doctors, researchers and nurses who provide care for the thousands of patients that come through their doors.
- Clinical trials
- Pleural effusions
- Pleural mesothelioma
- Radiation oncology
- Thoracic surgery
- National Comprehensive Cancer Network Member
- NCI-designated Case Comprehensive Cancer Center
- Ranked #1 for Cancer Care by U.S. News & World Report
- Thoracic Surgeons ranked #1 by U.S. News & World Report
Mesothelioma Clinical Trials at The Cleveland Clinic
The following clinical trials are in progress or actively recruiting participants at The Cleveland Clinic:
Study of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma Patients
Conditions: Mesothelioma Last Updated: July 1, 2019 Status: Active, not recruiting
Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy
Conditions: Malignant Mesothelioma Last Updated: March 4, 2019 Status: Active, not recruiting
Author: Linda Molinari
Editor in Chief, Mesothelioma Cancer AllianceRead about Linda
Reviewer: Annette Charlevois
Patient Support CoordinatorRead about Annette